Table 1. Clinical Characteristics.
| No PAF on 7-d-Holter monitoring(n = 185) | PAF on 7-d-Holter monitoring(n = 23) | p-value | |
| Demographics | |||
| Female | 77 (41.6%) | 13 (56.5%) | 0.174 |
| Age (y) | 67±13 | 76±12 | 0.003 |
| BMI (kg/m2) | 27.4±5.3 | 27.6±6.2 | 0.828 |
| Risk factors and history | |||
| SBP (mmHg) | 143±22 | 159±25 | 0.002 |
| DBP (mmHg) | 79±13 | 81±15 | 0.361 |
| Heart rate (1/min) | 74±15 | 65±12 | 0.018 |
| Temperature (°C) | 36.7±0.4 | 36.9±0.5 | 0.165 |
| History of stroke | 27 (14.6%) | 5 (21.7%) | 0.370 |
| History of TIA | 18 (9.7%) | 0 (0.0%) | 0.118 |
| Heart failure | 10 (5.4%) | 0 (0.0%) | 0.253 |
| Hypertension | 130 (70.3%) | 20 (87.0%) | 0.092 |
| Diabetes | 41 (22.2%) | 5 (21.7%) | 0.963 |
| Smoker | 49 (26.5%) | 3 (13.0%) | 0.106 |
| Hyperlipidemia | 58 (31.4%) | 12 (52.2%) | 0.046 |
| Coronary artery disease | 20 (10.8%) | 4 (17.4%) | 0.352 |
| Peripheral artery disease | 5 (2.7%) | 1 (4.3%) | 0.657 |
| Laboratory | |||
| Creatinine (mg/dL) | 0.97±0.54 | 0.95±0.50 | 0.865 |
| Glucose (mg/dL) | 130±54 | 126±34 | 0.778 |
| Total cholesterol (mg/dL) | 197±46 | 210±53 | 0.233 |
| LDL cholesterol (mg/dL) | 130±40 | 138±42 | 0.400 |
| HDL cholesterol (mg/dL) | 51±13 | 54±20 | 0.291 |
| Triglycerides (mg/dL) | 132±68 | 112±47 | 0.177 |
| HbA1c (%) | 6.2±1.1 | 6.5±1.7 | 0.337 |
| Stroke severity | |||
| TIA | 67 (36.2%) | 1 (4.3%) | |
| Minor stroke | 50 (27.0%) | 7 (30.4%) | 0.005 |
| Major stroke | 68 (36.8%) | 15 (65.2%) | |
| NIHSS | 3±4 | 6±4 | <0.001 |
| MRS | 2±1 | 3±1 | 0.006 |
| ESVEA | |||
| APB/h | 4 [1]; [14] | 29 [9; 143] | <0.001 |
| SV-run24h (beats) | 0 [0; 8] | 10 [5]; [21] | <0.001 |